
BAFF- And APRIL-Targeted Therapies Market Sees Surge In Activity Amid Rising Autoimmune Disease Burden Delveinsight
(MENAFN- PR Newswire) The BAFF- and APRIL-targeted therapies market is experiencing steady growth driven by the rising prevalence of autoimmune diseases such as systemic lupus erythematosus (SLE), IgA nephropathy, and Sjögren's syndrome. Advancements …